Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-03

Study Completion Date

2023-06-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to investigate the existence of clonal hematopoiesis of indeterminate potential (CHIP) in patients with a history of venous thromboembolism.

The study investigators make the assumption that these patients present mutations involved in CHIP occurrence.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism

NCT04211181

Venous Thromboembolic Disease Pulmonary Embolism Venous Thromboembolism +2 more

RECRUITING NA

Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study

NCT05396157

Thrombosis, Venous Bleeding Hemorrhage Venous Thromboembolic Disease +2 more

ACTIVE_NOT_RECRUITING

Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer

NCT02407717

Hemorrhage Vein Thrombosis

COMPLETED

Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Thrombosis

NCT03265054

Venous Thromboembolism (VTE)

UNKNOWN

Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism

NCT00788736

Venous Thromboembolism

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Thromboembolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Unprovoked proximal deep vein thrombosis

No interventions assigned to this group

Provoked distal deep vein thrombosis

No interventions assigned to this group

age-matched control group with no history of vein thrombosis

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women over 50 years old who have consulted at the Hematology laboratory of the Nîmes University Hospital for the occurrence or history of venous thromboembolism
* Patient who has accepted that their DNA was kept and used in the context of research on venous thromboembolism (biobank (registration number DC-2008-290 and authorization number AC-2008-107))